Analyst Ratings for CASI Pharmaceuticals (CASI)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/2/2021 | Mizuho | Mara Goldstein | New Coverage | Outperform (N/A) |
3.80 (N/A) |
0.90 (0.21) |
-76.67% | Details |
| 5/18/2021 | BTIG » Updated 11/16/2022 |
Justin Zelin | New Coverage | Buy (N/A) |
10.00 (21.00) |
1.45 (0.21) |
-85.52% | Details |
 |
||||||||
|
||||||||
|
||||||||
